SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-123680
Filing Date
2020-11-10
Accepted
2020-11-10 17:28:12
Documents
15
Period of Report
2020-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035599d1_8k.htm   iXBRL 8-K 40532
2 EXHIBIT 99.1 tm2035599d1_ex99-1.htm EX-99.1 91320
3 EXHIBIT 99.2 tm2035599d1_ex99-2.htm EX-99.2 15721
4 GRAPHIC image_001.jpg GRAPHIC 4340
  Complete submission text file 0001104659-20-123680.txt   347733

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nvax-20201107.xsd EX-101.SCH 3183
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20201107_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20201107_pre.xml EX-101.PRE 22708
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2035599d1_8k_htm.xml XML 3483
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 201302291
SIC: 2836 Biological Products, (No Diagnostic Substances)